3002.13.00.90/Cetuximab Bulk Active/Japan

Cetuximab Bulk Active from Japan

Cetuximab targets EGFR for colorectal cancer treatment as monoclonal antibody. Unmixed form under HTS 3002.13.0090 as per immunological product notes. Biotechnologically produced.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• EGFR specificity assays required for validation

• Avoid animal facility imports without vet clearance

• pH stability critical for classification